EssilorLuxottica (OTCMKTS:ESLOY) Sees Strong Trading Volume – What’s Next?

Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) saw unusually-strong trading volume on Friday . Approximately 286,351 shares changed hands during mid-day trading, an increase of 133% from the previous session’s volume of 123,027 shares.The stock last traded at $95.03 and had previously closed at $94.60.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of EssilorLuxottica in a research report on Tuesday, May 12th. They set a “hold” rating for the company. The Goldman Sachs Group downgraded EssilorLuxottica from a “buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Finally, Zacks Research lowered EssilorLuxottica from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 23rd. Two investment analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy”.

EssilorLuxottica Stock Performance

The stock’s 50-day moving average is $98.41 and its two-hundred day moving average is $117.32. The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.